
Lisbeth C. Robinson
Examiner (ID: 5993, Phone: (571)270-7463 , Office: P/1611 )
| Most Active Art Unit | 1611 |
| Art Unit(s) | 1611 |
| Total Applications | 240 |
| Issued Applications | 64 |
| Pending Applications | 1 |
| Abandoned Applications | 173 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10225906
[patent_doc_number] => 20150110899
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-23
[patent_title] => 'PHARMACEUTICAL FORMULATIONS OF NITRITE AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/579767
[patent_app_country] => US
[patent_app_date] => 2014-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 26228
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14579767
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/579767 | PHARMACEUTICAL FORMULATIONS OF NITRITE AND USES THEREOF | Dec 21, 2014 | Abandoned |
Array
(
[id] => 10201649
[patent_doc_number] => 20150086637
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-26
[patent_title] => 'NOVEL COMPOSITION FOR TREATMENT OF ESSENTIAL THROMBOCYTHEMIA'
[patent_app_type] => utility
[patent_app_number] => 14/555256
[patent_app_country] => US
[patent_app_date] => 2014-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7187
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14555256
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/555256 | NOVEL COMPOSITION FOR TREATMENT OF ESSENTIAL THROMBOCYTHEMIA | Nov 25, 2014 | Abandoned |
Array
(
[id] => 10256379
[patent_doc_number] => 20150141376
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-21
[patent_title] => 'Pharmaceutical compositions of anti-viral compounds and process for preparation thereof'
[patent_app_type] => utility
[patent_app_number] => 14/544041
[patent_app_country] => US
[patent_app_date] => 2014-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6444
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14544041
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/544041 | Pharmaceutical compositions of anti-viral compounds and process for preparation thereof | Nov 17, 2014 | Abandoned |
Array
(
[id] => 10219512
[patent_doc_number] => 20150104505
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-16
[patent_title] => 'COATED PHARMACEUTICAL CAPSULE DOSAGE FORM'
[patent_app_type] => utility
[patent_app_number] => 14/502952
[patent_app_country] => US
[patent_app_date] => 2014-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6967
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14502952
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/502952 | COATED PHARMACEUTICAL CAPSULE DOSAGE FORM | Sep 29, 2014 | Abandoned |
Array
(
[id] => 9864263
[patent_doc_number] => 20150044282
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-02-12
[patent_title] => 'ABUSE RESISTANT FORMS OF IMMEDIATE RELEASE OXYCODONE, METHOD OF USE AND METHOD OF MAKING'
[patent_app_type] => utility
[patent_app_number] => 14/494148
[patent_app_country] => US
[patent_app_date] => 2014-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 13849
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14494148
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/494148 | ABUSE RESISTANT FORMS OF IMMEDIATE RELEASE OXYCODONE, METHOD OF USE AND METHOD OF MAKING | Sep 22, 2014 | Abandoned |
Array
(
[id] => 9910517
[patent_doc_number] => 20150065719
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-05
[patent_title] => 'PHARMACEUTICAL COMPOSITIONS COMPRISING N-(4-(2-AMINO-3-CHLOROPYRIDIN-4-YLOXY)-3-FLUOROPHENYL)-4-ETHOXY-1-(4-FLUOROPHENYL)-2-OXO-1,2-DIHYDROPYRIDINE-3-CARBOXAMIDE'
[patent_app_type] => utility
[patent_app_number] => 14/486139
[patent_app_country] => US
[patent_app_date] => 2014-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 18624
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14486139
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/486139 | Pharmaceutical compositions comprising N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide | Sep 14, 2014 | Issued |
Array
(
[id] => 10974328
[patent_doc_number] => 20140377364
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-25
[patent_title] => 'ACTIVE INGREDIENT DELIVERY SYSTEM'
[patent_app_type] => utility
[patent_app_number] => 14/481650
[patent_app_country] => US
[patent_app_date] => 2014-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7074
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14481650
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/481650 | ACTIVE INGREDIENT DELIVERY SYSTEM | Sep 8, 2014 | Abandoned |
Array
(
[id] => 9910375
[patent_doc_number] => 20150065577
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-05
[patent_title] => 'METHOD OF TREATING BINGE EATING DISORDER'
[patent_app_type] => utility
[patent_app_number] => 14/464249
[patent_app_country] => US
[patent_app_date] => 2014-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12341
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14464249
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/464249 | METHOD OF TREATING BINGE EATING DISORDER | Aug 19, 2014 | Abandoned |
Array
(
[id] => 10920475
[patent_doc_number] => 20140323495
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-30
[patent_title] => 'Stabilized Amorphous Forms of Imatinib Mesylate'
[patent_app_type] => utility
[patent_app_number] => 14/331703
[patent_app_country] => US
[patent_app_date] => 2014-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4252
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14331703
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/331703 | Stabilized Amorphous Forms of Imatinib Mesylate | Jul 14, 2014 | Abandoned |
Array
(
[id] => 10911685
[patent_doc_number] => 20140314701
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-23
[patent_title] => 'ANHYDROUS LIQUID ANTIPERSPIRANT COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 14/321893
[patent_app_country] => US
[patent_app_date] => 2014-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8626
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14321893
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/321893 | ANHYDROUS LIQUID ANTIPERSPIRANT COMPOSITION | Jul 1, 2014 | Abandoned |
Array
(
[id] => 10735785
[patent_doc_number] => 20160081935
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-24
[patent_title] => 'DOSAGE FORMS FOR ORAL ADMINISTRATION OF ACTIVE SUBSTANCES'
[patent_app_type] => utility
[patent_app_number] => 14/786496
[patent_app_country] => US
[patent_app_date] => 2014-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7051
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14786496
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/786496 | DOSAGE FORMS FOR ORAL ADMINISTRATION OF ACTIVE SUBSTANCES | Apr 21, 2014 | Abandoned |
Array
(
[id] => 9642016
[patent_doc_number] => 20140220128
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-07
[patent_title] => 'Solid Dosage Form'
[patent_app_type] => utility
[patent_app_number] => 14/251805
[patent_app_country] => US
[patent_app_date] => 2014-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4087
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14251805
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/251805 | Solid Dosage Form | Apr 13, 2014 | Abandoned |
Array
(
[id] => 9634269
[patent_doc_number] => 20140212377
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-31
[patent_title] => 'SCENTED CAMO'
[patent_app_type] => utility
[patent_app_number] => 14/251708
[patent_app_country] => US
[patent_app_date] => 2014-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1288
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14251708
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/251708 | SCENTED CAMO | Apr 13, 2014 | Abandoned |
Array
(
[id] => 9995472
[patent_doc_number] => 09040066
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-05-26
[patent_title] => 'Skin rejuvenation cream'
[patent_app_type] => utility
[patent_app_number] => 14/246242
[patent_app_country] => US
[patent_app_date] => 2014-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10548
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14246242
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/246242 | Skin rejuvenation cream | Apr 6, 2014 | Issued |
Array
(
[id] => 10932183
[patent_doc_number] => 20140335205
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-13
[patent_title] => 'MATERIALS AND METHODS FOR TREATMENT OF DISORDERS ASSOCIATED WITH OXIDATIVE STRESS'
[patent_app_type] => utility
[patent_app_number] => 14/242479
[patent_app_country] => US
[patent_app_date] => 2014-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20582
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14242479
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/242479 | MATERIALS AND METHODS FOR TREATMENT OF DISORDERS ASSOCIATED WITH OXIDATIVE STRESS | Mar 31, 2014 | Abandoned |
Array
(
[id] => 12527550
[patent_doc_number] => 10006029
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-26
[patent_title] => Methods of treating colorectal cancer
[patent_app_type] => utility
[patent_app_number] => 14/211471
[patent_app_country] => US
[patent_app_date] => 2014-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9739
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14211471
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/211471 | Methods of treating colorectal cancer | Mar 13, 2014 | Issued |
Array
(
[id] => 11242659
[patent_doc_number] => 09468686
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-10-18
[patent_title] => 'Solutions comprising polyethylene glycol and electrolytes'
[patent_app_type] => utility
[patent_app_number] => 14/166716
[patent_app_country] => US
[patent_app_date] => 2014-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16223
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14166716
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/166716 | Solutions comprising polyethylene glycol and electrolytes | Jan 27, 2014 | Issued |
Array
(
[id] => 9462877
[patent_doc_number] => 20140127304
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-08
[patent_title] => 'PROCESS FOR PREPARING SOLID AMORPHOUS PARTICLES COMPRISING TIOTROPIUM BROMIDE AND A CO-SOLID'
[patent_app_type] => utility
[patent_app_number] => 14/151172
[patent_app_country] => US
[patent_app_date] => 2014-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2557
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14151172
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/151172 | PROCESS FOR PREPARING SOLID AMORPHOUS PARTICLES COMPRISING TIOTROPIUM BROMIDE AND A CO-SOLID | Jan 8, 2014 | Abandoned |
Array
(
[id] => 10430504
[patent_doc_number] => 20150315516
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-05
[patent_title] => 'ODORANTS OF THE VIOLET TYPE'
[patent_app_type] => utility
[patent_app_number] => 14/650140
[patent_app_country] => US
[patent_app_date] => 2013-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4903
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14650140
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/650140 | Odorants of the violet type | Nov 24, 2013 | Issued |
Array
(
[id] => 10728404
[patent_doc_number] => 20160074553
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-17
[patent_title] => 'DRESSING FOR COMPROMISED WOUND HEALING'
[patent_app_type] => utility
[patent_app_number] => 14/442539
[patent_app_country] => US
[patent_app_date] => 2013-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 13240
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14442539
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/442539 | DRESSING FOR COMPROMISED WOUND HEALING | Nov 7, 2013 | Abandoned |